Yong Ben

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Aaron Chan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yong Ben:

Company Role Class Num Shares Value Price $ Report Date Ownership
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock, par value $0.0001 per share 2,783 $83,490 $30.00 30 May 2024 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Common Stock, par value $0.0001 per share 7,583 $56,645 $7.47 30 May 2025 Direct
BridgeBio Oncology Therapeutics, Inc. Chief Med & Dev Officer Stock Option (Right to Buy) 357,177 26 Aug 2025 Direct
Corbus Pharmaceuticals Holdings, Inc. Director Stock options (right to buy) 16,000 30 May 2025 Direct

Insider Reports Filed by Yong Ben

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HLXB BridgeBio Oncology Therapeutics, Inc. 26 Aug 2025 1 $0 4 Chief Med & Dev Officer 28 Aug 2025, 16:37
HLXB BridgeBio Oncology Therapeutics, Inc. 11 Aug 2025 0 $0 3 Chief Med & Dev Officer 18 Aug 2025, 17:11
CRBP Corbus Pharmaceuticals Holdings, Inc. 30 May 2025 2 $0 4 Director 02 Jun 2025, 16:30
CRBP Corbus Pharmaceuticals Holdings, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:28
CRBP Corbus Pharmaceuticals Holdings, Inc. 16 May 2024 1 $0 4 Director 20 May 2024, 16:54
CRBP Corbus Pharmaceuticals Holdings, Inc. 18 May 2023 1 $0 4 Director 22 May 2023, 16:20
CRBP Corbus Pharmaceuticals Holdings, Inc. 06 Mar 2023 1 $0 4 Director 07 Mar 2023, 09:19
CRBP Corbus Pharmaceuticals Holdings, Inc. 06 Mar 2023 0 $0 3 Director 07 Mar 2023, 09:14